Home
by Erős Pista Mon 25 Oct - 11:03super.
— Šesta kolona (@haarppp) October 25, 2021
da li bi vax genijalci objasnili nama antivax imbecilima zašto u vijetnamu do vaknacije praktično nije bilo korone? https://t.co/V8owbi18Nz pic.twitter.com/OdFoT8ORQ5
https://thediplomat.com/2021/06/what-explains-vietnams-current-covid-19-struggles/
What caused this reversal? No doubt Vietnam has been a victim of its own success. With such low rates of infection, it simply did not pursue vaccines with any urgency. It did contract for supplies of vaccines, but did so relatively late to the game, and far back in the queue.
With new variants and an economy that was in the midst of re-opening, half of Vietnam’s 8,000 COVID-19 cases – admittedly still a very low figure overall – have come since April. Spurred by these fresh outbreaks, by early June, the government had contracted 31 million doses of Pfizer’s vaccine by the end of the year; 38.9 million doses of AstraZeneca from COVAX, plus 30 million in a corporate purchase; and reached a purchase agreement for 50-150 million doses of Russia’s Sputnik V. In addition, Vietnam is in talks with Taiwan’s Medigen for 3-10 million doses and with Moderna for an unspecified number of doses.
In all, Vietnam has secured over 170 million doses, enough to achieve herd immunity. It’s just that they will not be delivered until the end of 2021 or early 2022. For this reason, the government has now authorized the Sinopharm vaccine from China, and is now under pressure to begin imports immediately, despite a potential nationalist backlash and the overall suspicion of the Vietnamese public.
2 minuta guglanja.
